| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/2007 | EP1778282A1 Mutated hiv nef for modulating immunity |
| 05/02/2007 | EP1778281A1 Vaccination of skunks and/or mongooses against rabies |
| 05/02/2007 | EP1778280A1 Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection |
| 05/02/2007 | EP1778275A2 Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
| 05/02/2007 | EP1778270A2 Bispecific binding agents for modulating biological activity |
| 05/02/2007 | EP1778188A1 Spray-dried powders containing at least one 1,4 o-linked saccharose derivative and methods for producing the same |
| 05/02/2007 | EP1778186A1 Method for preparation of poly-iclc and uses thereof |
| 05/02/2007 | EP1778182A1 Stable compositions containing outer membrane vesicles, methods of manufacturing |
| 05/02/2007 | EP1465658B1 ORAL VACCINATION WITH THE TUMOR ANTIGEN MIMOTOPE Gln-Met-Trp-Ala-Pro-Gln-Trp-Gly-Pro-Asp |
| 05/02/2007 | EP1365797B1 Antibodies modulating the upa/upar interaction and uses thereof |
| 05/02/2007 | EP1345658B1 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1255769B1 Universal procedure for refolding recombinant proteins |
| 05/02/2007 | EP1100921B1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | EP1077069B1 Preventives/remedies for hepatic cirrhosis |
| 05/02/2007 | EP1009846B1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection |
| 05/02/2007 | EP1004313B1 Cachexia remedy |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0953047B1 Vaccine containing a peroxiredoxin |
| 05/02/2007 | EP0906426B1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 05/02/2007 | EP0885300B1 Transferrin receptor genes of moraxella |
| 05/02/2007 | EP0689586B1 Vpr function and activity |
| 05/02/2007 | CN1956738A Antibodies to MAdCAM |
| 05/02/2007 | CN1956731A Anti-CD52 antibody treatment for diabetes |
| 05/02/2007 | CN1956730A Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, and therapeutic uses thereof |
| 05/02/2007 | CN1956729A Vaccines |
| 05/02/2007 | CN1956727A Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/02/2007 | CN1956718A Compositions comprising immunomodulatory compounds for the treatment and management of skin diseases and disorders, and method of using the same |
| 05/02/2007 | CN1313617C Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 05/02/2007 | CN1313605C Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method |
| 05/02/2007 | CN1313603C Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application |
| 05/02/2007 | CN1313484C 12 amino acid analog epi-position of human B cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position |
| 05/02/2007 | CN1313481C Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/02/2007 | CN1313441C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313153C Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
| 05/02/2007 | CN1313152C Vaccines |
| 05/02/2007 | CN1313151C Preparation of high-performance noncellular vaccine and usage |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/01/2007 | US7211569 Synthetic human papilloma virus genes |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211445 Conjugation of biomolecules using diels-alder cycloaddition |
| 05/01/2007 | US7211432 Foreign nucleic acid molecule encoding multiple costimulatory molecules, such as B7-1 or B7-2 (antigents), intercellular adhesion molecules and leukocyte function associated antigen-3 |
| 05/01/2007 | US7211411 Human papilloma virus treatment |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211379 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 05/01/2007 | US7211265 Vaccination modalities |
| 05/01/2007 | US7211264 Salmonella pathogenicity island two (Spi2) double mutant for use as tool in developing vaccine for treatment and prevention of microorganismal and viral infcetions |
| 05/01/2007 | US7211263 Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella |
| 05/01/2007 | US7211262 Burn pain treatment by peripheral administration of a neurotoxin |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | US7211260 Infectious bursitis vaccine |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | US7211256 Administering to mammal polyclonal or monoclonal antibody, wherein polyclonal or monoclonal antibody recognizes an epitope of a protein of 48,000 daltons determined by immunoblot, wherein protein is a surface protein of a merozoite of Plasmodium falciparum |
| 05/01/2007 | US7211255 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
| 05/01/2007 | US7211253 Erythropoietin forms with improved properties |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | CA2234585C Prolonged release of gm-csf |
| 05/01/2007 | CA2192215C Recombinant aav genome encoding immunodeficiency virus protein |
| 05/01/2007 | CA2191440C Treatment and prevention of helicobacter infection |
| 05/01/2007 | CA2154689C Improved immunotherapeutic composition |
| 05/01/2007 | CA2140091C Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 |
| 05/01/2007 | CA2121497C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 05/01/2007 | CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
| 04/26/2007 | WO2007048127A2 Fc labeling for immunostaining and immunotargeting |
| 04/26/2007 | WO2007048077A2 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 04/26/2007 | WO2007047981A2 Tumor-targeted nanodelivery systems to improve early mri detection of cancer |
| 04/26/2007 | WO2007047967A2 Detoxification depot for alzheimer's disease |
| 04/26/2007 | WO2007047938A2 Influenza viruses able to infect canids, uses thereof |
| 04/26/2007 | WO2007047916A2 Multiclade hiv vaccines |
| 04/26/2007 | WO2007047831A2 Functional influenza virus like particles (vlps) |
| 04/26/2007 | WO2007047763A2 Bcr-abl vaccines and methods of use thereof |
| 04/26/2007 | WO2007047749A1 Mucosal and systemic immunizations with alphavirus replicon particles |
| 04/26/2007 | WO2007047728A2 Compositions and methods for the treatment of canine influenza virus disease |
| 04/26/2007 | WO2007047626A1 Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis |
| 04/26/2007 | WO2007047609A2 INHIBITION OF PLACENTA GROWTH FACTOR (PlGF) MEDICATED METASTASIS AND/OR ANGIOGENESIS |
| 04/26/2007 | WO2007047579A2 A novel therapeutic target for protozoal diseases |
| 04/26/2007 | WO2007047573A2 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods |
| 04/26/2007 | WO2007047501A2 Outer membrane vesicles: novel vaccine for gram-negative biothreat agents |
| 04/26/2007 | WO2007047436A2 Methods and materials for producing a generic anti-amyloid immune response in mammals |
| 04/26/2007 | WO2007047235A2 Compositions and methods for treatment of airway hypersecretion |
| 04/26/2007 | WO2007047189A2 Targeted biocides |
| 04/26/2007 | WO2007047112A2 Anti-myostatin antibodies |
| 04/26/2007 | WO2007046893A2 Methods for generating bioactive assemblies and uses thereof |
| 04/26/2007 | WO2007046839A2 New live virus vaccines |
| 04/26/2007 | WO2007046834A2 Glp-1 agonists, compositions, methods and uses |
| 04/26/2007 | WO2007046489A1 Therapeutic agent for heart disease |
| 04/26/2007 | WO2007045927A2 Therapeutic agent |
| 04/26/2007 | WO2007045911A1 Integral membrane protein |
| 04/26/2007 | WO2007045674A1 Production influenza virus vaccines |
| 04/26/2007 | WO2007045469A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 04/26/2007 | WO2007045389A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 04/26/2007 | WO2007017242A3 Novel virus reduction method based on detergents and shearing forces |
| 04/26/2007 | WO2007012944A3 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 04/26/2007 | WO2007012671A3 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method |